Tag Archives: COI

Peer review of: Charlotta Pisinger et al. (U Copenhagen public health), A conflict of interest is strongly associated with tobacco industry-favourable results, indicating no harm of e-cigarettes, Preventive Medicine 2018.

by Carl V Phillips

For an overview of this collection and an explanation of the format of this post, please see this brief footnote post.

The paper reviewed here is not available on Sci-Hub at the moment, or anywhere else (I will add a link if someone finds one). The abstract and portal to the paywalled version are here. And, yes, that series of words really is the garbled title the paper was published with.


This is one of the worst tobacco control papers of the year, and that is a high bar. It suffers from multiple layers of fatal flaws. On the upside, most anti-THR junk science is pretty unremarkable — the usual problems of using flawed methodology, erroneously assuming associations represent causation in a particular direction, statistical games, model fishing, etc. Several of those problems are present here too, along with others, thus creating value as a broad tour of the blatant biases and slipshod work that permeate tobacco control, as well as the low quality of what passes for qualitative public health research more generally.

The authors reviewed 94 journal articles (actually just a few sentence of the abstracts) about vapor product chemistry or effects of in vitro exposures (an undifferentiated muddle of incommensurate papers, which is itself a fatal flaw, though totally overshadowed by far larger flaws). They claim to assess the conflict of interest (COI) of the authors of each paper, though they do not. Then they do some statistics and imply that having industry-related COI causes authors to… well, do something bad, I guess, though this neither stated nor supported by the analysis.

Just to get the most absurd flaw in the paper out of the way: In the title, the conclusion statement of the abstract, and elsewhere in the paper, the authors assert that many of the papers they reviewed claimed that vaping is harmless. I am not going to re-review their database to see, but I would be shocked if there were even two papers that said anything that could even be interpreted that way, and I would guess it is actually zero. Even a poor scientist would know enough to not claim that the one bit of chemistry or toxicology they assessed would support a claim of “harmless”. I would be shocked if there was a single paper by tobacco-industry-employed researchers in the entire modern literature that made that mistake, and fairly shocked if any researcher funded by a serious company was so clueless as to do so.

The authors’ own erroneous denial of COI…

Normally reviews in this collection mention the (seemingly inevitable) dishonest denial of COI by tobacco controllers as a brief aside at the end. But for a paper that is supposedly about COI, it is worth headlining. The authors claimed:

Conflicts of interest: CP and AMB state that they have no conflict of interest. NG has accepted several invitations (travel expenses, accommodation and conference fee) from the pharmaceutical industry to take part in international medical conferences in the last five years.

The paper itself makes clear that the authors have a serious anti-industry bias, which is a huge COI for any paper about vaping. Indeed, the content of the paper suggests this reaches the level of being a fatal problem for this particular analysis: it rendered them incapable of doing any legitimate work. But even if it is not that bad, it obviously is not “no conflict of interest.” The first author is an anti-vaping activist; she has written nothing of importance, but we can see from her anti-vaping testimony to the EU in 2013 and this recent commentary that she has long practiced anti-vaping activism, and is willing to make absurd claims in pursuit of that conflicting interest. [Update: Someone has noted in the comments that she has also previously acknowledged doing work for pharma.] The second author, Nina Godtfredsen, has written no apparent anti-vaping commentaries, but has long been involved with institutional tobacco control. The third author could probably get away with the “no COI” claim based on her lack of publications. But for all of them there is still obvious bias evident in the paper, as well as their financial COI described below.

…and the related failure to do their own research correctly.

The authors’ obliviousness to their own COIs, as demonstrated in the above dishonest “disclosure”, create the next fatal flaw in the paper itself, the notion that a large portion of authors had no conflict of interest. The authors assessed only whether the authors of the papers in their dataset had any funding relationship with industry, or with one of (only) three anti-vaping funders (NIH, FDA, and WHO). But, as anyone who actually understands the concept of COI knows, funding is only one of many COIs, and is seldom the most important. Everyone writing in this space has non-financial COIs. Moreover, the types of funding relationships described in papers’ front- and end-matter are only one of many financial COIs, and are often not the most important. For example, a one-off grant to write a paper is a far less important financial COI than working for a university department that, for other projects, gets substantial ongoing funding from an interested agency.

Also, in case you have an inclination to give the authors credit for trying to assess the effects of NIH/FDA/WHO funding (why just those three??), note that they wrote, “Ten out of 63 studies without a conflict of interest were funded by NIH, FDA or WHO” (emphasis added). That is just funny.

This error only became fatal upon publication. If anyone who understood the concept of COI had been involved in editing or reviewing this paper for the journal, or merely been asked to comment on a manuscript, they could have fixed the problem: They would have just told the authors to replace the absurd “no conflict of interest” category and language with “no industry funding” or some other description of what they actually claimed(!) to have coded. But apparently no one with any expertise in the titular subject matter ever read the paper before it appeared in a journal.

That would have saved the authors from broadcasting how little they understand COI quite so loudly. However, it would not have solved the next layer of fatal error, in which they fail to understand even financial COI. Their methodology for assigning COI scores is opaque, and basically could be described as “what the first author thought the coding should be.” There are some words, but they are a muddle. There is no clue exactly what the key word “sponsored” means (let alone “partially sponsored”), and no indication which entities counted for which category (would FSFW count as “the tobacco industry” in their minds? probably, but they do not say). There is a vague explanation for what information was used, and it appears to just be the front- and end-matter of the paper (funding acknowledgments, institutional affiliations), or that in other papers by the same authors for publications that omit that information. Presumably the authors could provide some clarification if asked, so the sloppy reporting of the methods is mostly a testament to how unserious both the authors and the journal process were.

Financial COIs are not homogeneous.

The bigger problem here is that the authors apparently do not understand how different types of funding create different COIs. A one-off grant, actually working for CDC or PMI, and an ongoing center grant are very different. An investigator-initiated project, whatever funding it manages to get, is very different from a funder issuing a highly-specific RFP or contract. An unrestricted pool of research money is different from a funded predefined research program. Figuring out exactly how to score these differently would be tricky, but the authors seem oblivious to the fact that you need to at least try.

Also, funders vary. It is difficult to imagine FDA renewing a center grant if the researchers produced a series of papers that undermined FDA’s political agenda, and tobacco control funders have a history of cutting off funding when they do not like someone’s results. It is equally difficult to imagine a major tobacco company cutting off someone’s funds for publishing an inconvenient result. Thus, external grants from some funders create huge conflicting interests to support an agenda, while other funders — major tobacco companies in particular, who would not dare do so even if they were inclined — are very unlikely to impose pressure for particular results.

Chances are that these authors (and others who think this paper has any value) are unaware of this fact. If they are aware, their political views (i.e., their COIs!) presumably would result in them ignoring it. But even conceding that, it is still a fatal error to just lump all financial relationships into the categories “fully sponsored” research, “partially sponsored”, and other funding relationships. Indeed, the latter category in this ordered ranking is potentially more influential for someone who is inclined to cook her results to please a funder. Which is more enticing, getting your department a few thousand dollars to hire a student RA, or getting an personal honorarium and expenses to jet off to a conference to present the results?

Then there are the various financial COIs that do not appear in the end-matter. As already noted, an operation (e.g., university department) may be very beholden to funding from a particular political faction in the tobacco wars (read: from institutional tobacco control), regardless of the funding for the current paper. It seems safe to assume that these authors know that if they had they had actually written the analysis they pretended to, genuinely assessing the COIs of paper authors (assessing commentaries they had published; looking into their departments’ funding; etc.) and reporting them (e.g., noting that some of the authors are anti-vaping activists), then they would have been off the tobacco control gravy train for the rest of their careers. Even more so if they had assessed the quality of the research rather than just glancing at the abstracts. Grant funding for a paper does not create a financial COI — the money is already pocketed. The grant funding you want for your next paper, or for the rest of your career, does. (Past funding may create a COI in terms of disposition or attitude, but these authors were ignoring all such COIs.)

One subtle problem that is baked into the methodology, hardly worth mentioning given the major problems, is that the authors chose to code papers the same if all the authors had some affiliation or just one of them. Good independent research projects tend to assemble ad hoc groups of authors, with a reasonable chance that at least one is expert enough to have consulted for industry, so they would get coded as if they were industry projects.

The authors make no attempt to assess the quality of the papers they reviewed.

But let’s move on and counterfactually imagine having a useful measure of the COI that potentially affects each paper in some collection. What should someone do then? The most useful task would be to look at the methodologies to see if the study designs (what questions were being asked, what apparatus were used and how, quantities, etc.) seemed to be biased in ways that would advance the apparent conflicting interests. In particular, it would have been interesting to know which papers have been lambasted in public comments for their methodological failures (e.g., the ones in this collection that overheated the coils, thereby producing a cocktail of nasty chemicals that no one would ever vape). But that is not what the authors did. Indeed is apparently way over their heads. They presumably lack the understanding of the relevant science to assess the methods themselves (suggesting that perhaps they had no business undertaking this project without a coauthor who could), and it seems unlikely they are even capable of assessing which third-party criticisms of the methods are valid.

So instead they claim(!) to have looked at the results. That would not be useless, and writing “the authors really should have written this other paper I would rather read, even though it would have been beyond their ken” is never great in a review. But it should be recognized that this is a clearly inferior approach: Results differ from true values of what is purportedly being measured due to a combination of identifiable study design biases, hidden biases that even the study authors might not be able to recognize, and random error.

They did not even really look at the results.

Except they really did not look at the results. They really just looked at the conclusion sentence in the abstract. First, only the abstracts were reviewed. The authors rationalized this lazy approach by claiming it was done not because they only had two days to spend on this, but to represent the “real-life scenario” of most readers only looking at the abstract. That is actually useful to analyze and report, though it is inexcusable that they made no attempt to also assess whether what was reported in the abstract accurately represented the results of the study. Abstracts that misrepresent the results are, of course, a common manifestation of anti-tobacco COIs, and thus a particularly good way to assess whether COI influenced the reporting. Thus, the representation by the authors that they assessed the results of the studies is simply false.

The second and third authors — who appear to be unqualified to answer the question in most cases — coded each abstract for “Do the results indicate potential harm to health?” This is a scientifically illiterate question when asked without quantification; any analytic chemistry result and any toxicology result other than “no effect whatsoever was detected” (which presumably never happened) will contain information about some potential harm to health. Anyone who would ask this question (let alone sometimes answer “no”) is clearly unqualified to do this analysis. Presumably they were really just answering this question based on the stated conclusions, not the results. Thus, their two coding questions really become a one question with an ad hoc element of quantification (i.e., the first is just a less sensitive version of the second).

The second question they coded, which is clearly what they were really interested in (and, sadly, genuinely closer to the typical know-nothing “real-life” method of reading practiced by supporters of tobacco control) was “What are the conclusions? (1. Concern that e-cigarettes might harm users’ health or public health; 2. No concern that e-cigarettes might harm users’ health or public health/recommend them as harm reduction strategies or 3. Unclear).” But as anyone who reads the tobacco control literature knows, such statements are just throw-away editorializing that seldom have anything to do with the actual research results. The only legitimate statement of concern or lack thereof would be “harmful levels of X were [not] detected in this study” or “the cellular effects detected in this study are [not] generally believed to represent real health risks.” It is slightly interesting to parse COIs against the usual editorializing to look for an association (spoiler: tobacco controllers throw in unsupported political editorializing in everything they write; industry researchers stick to the facts). But that, which is all they actually did, was not what these authors pretended to be doing.

The authors repeatedly make a big deal about how these assessments of the abstracts were blinded regarding authorship. This is comical. You would have to be dumb as a rock to not recognize the difference between a just-the-facts abstract written by a careful industry research team and the political screechings that are written by tobacco controllers. Yes, there is some middle ground, but not much.

Moreover, the stated coding for the second question is also scientifically illiterate. Anyone who does a single study of the types analyzed and draws any conclusion that would actively indicate “no concern” about exposure to vaping in general should be condemned for that, and perhaps that should be blamed on COI. Presumably approximately none of the abstracts actually said that. The stated “concern” that is coded as 1 (especially the bit about “public health”, which would require social science analysis, not just chemistry) is clearly just a measure of anti-vaping editorializing. It is possible to make a chemistry or toxicology discovery that raises alarm about some exposure, of course, but it happens that in the case of vaping there have been no such discoveries. Thus any stated “concern” is purely political.

In other words, this coding basically divides the world into authors who were actively editorializing (on the anti side) and those who just reported the facts. Whatever funding history makes someone more likely to fall into the latter category (spoiler: that would be avoiding institutional tobacco control funding) should be commended.

If the other aspects of the methods were not so unserious, it would be important that there is a big difference between where someone looks and what they do, a distinction the authors seem oblivious to. That is, a researcher that intended to concoct a politically favorable result might design the labs they are running to do that, or game how they report the results. Or they might just choose to assess something where they already know they will like the results. For example, an anti-vaping activist might choose to overheat the coil to produce a nasty cocktail, or he might just decide to observe whether there are detectable molecules of diacetyl or nitrosamines — already knowing there are — with the intention of spinning those trivial quantities as harmful. Alternatively, authors might do a study of COIs in which they design their coding to ensure that anti-vaping authors are said to have no COI, or they might just choose to observe whether high-quality industry research tends to produce reassuring results — already knowing it does — with the intention of spinning that as biased. (Or they might do both.) The omission of any attempt to assess how much of each of these is happening is pretty minor, given the other flaws, and is probably another “beyond their ken” point. But someone who was trying to do a serious version of the ostensible research would have done it.

Results (one is actually interesting!), unsupported conclusions, and the bizarrely absent conclusion.

The authors’ interpretation of the results from this train wreck methodology are hardly worth mentioning, let alone their silly use of statistical tests for the resulting trivial crosstabs (“hey, look at us, we is doing real scientifics!”). They dichotomized each of their codings, presumably in the way that produced the most dramatic results, but at this point who even cares about subtle clever ways of biasing the results.

Naturally, these “no conflict of interest” authors (LOL) concluded — after producing what is basically the observation that only non-industry studies tend to include absurd conclusions — with further absurdity: “a strong association between an industry–related conflict of interest and tobacco/e-cigarette industry–favourable results, indicating that e-cigarettes are harmless.” As already noted, presumably no one ever claimed the latter. Moreover, they never explain what they think an industry-favorable result even is, let alone make a case for why it is that. On top of that — and here is the craziest thing about this hot mess — they never actually claim that the COIs that (they assert without analysis) result from industry funding caused anything. Not once, here or anywhere else. It is not just that they do not propose a mechanism via which industry-associated researchers tried to get “industry-favourable [sic]” results (e.g., by only looking at the cleanest vapes or using too-small quantities). They do not ever even assert that those researchers tried to do so.

They literally wrote not a word about why the content of industry-associated abstracts might systematically differ from those of tobacco controllers. (The present review explains why; they did not even attempt to offer an alternative story.) They are so far down their rabbit hole of biased madness that they presumably think it goes without saying that the only possible explanation for the difference is that everything tobacco controllers write is valid and…? And what? Even if we pretend they made that counterfactual claim about tobacco control papers, they still fail to even assert that being associated with industry results in inaccurate study results. They are so blinded by their COIs that they do not even realize they forgot to say it. Of course, anyone who would take this paper seriously presumably lives in the same rabbit hole, so I suppose that does not matter much.

Their lack of ever even asserting that industry researchers do anything wrong, however, does not stop them from continuing with, “Some journals have already decided they will not publish tobacco industry–funded research. The present authors recommend all journals to follow in their footsteps.” Yes, that’s right. They made zero attempt to assess whether those studies used good methodology, or even whether they accurately represented their results. But then called for censoring them all because they did not inappropriately editorialize in these authors’ preferred direction. What more do you need to know about the COI of tobacco controllers?

Serious readers, unless they are trying to write a review, will probably not even bother to look at the reported results. But that would cause them to miss the one interesting result — interesting when assessed based on what was actually done and not what the authors pretend was done: “Analyses showed that there was no difference [sic: 94 and 100 are different] in findings of harm between studies funded by [NIH/FDA/WHO] (10/10, 100%) and studies without [sic: sarcastic] conflict of interest funded by other sources [sic: actual editing error] (48/51, 94.1%; p = 0.831).” The authors presumably do not realize that what they found is that authors they pretend have “no COI” were almost as likely to engage in anti-vaping political spin as those with the strongest financial incentives to do so. In other words, within the world of authors who avoid any industry affiliation (or are too unskilled to be invited to have one), the COIs that are driving their behavior are mostly non-financial. We already knew that, of course, but this is an interesting statistic in support of that.

Introduction and Discussion.

To round out this review: The Introduction is mostly just what you would expect, with random undergraduate-level discussion about vaping in general and various bits of ancient history, along with the usual pot-kettle ranting about COI. There are no references to any serious analyses of the concept of COI, nor a word about what the authors even think COI even is — unsurprisingly, since it is obvious they have no idea. Interestingly, however, there is a paragraph about how “contradictory” results in the literature may be driven by different methodologies. You might think that someone who wrote that would go on to actually look at methodologies, but no. (Also, the fact that they think of different results from different methodologies as “contradictory” is a deep indication of just how unsophisticated these authors are. They are basically telling us that they themselves are only capable of reading at that naive “real-life” level they used — i.e., they only understand asserted conclusions, not the actual science.)

The Discussion section is a remarkable self-own. This is not limited to the “strengths and limitations” paragraphs, though these might as well just have read “not only do we not understand what a legitimate analysis of this would have looked like, but we don’t even understand what we did.” They are utterly unaware of the actual limitations noted above (I would normally suggest that they might be pretending to be unaware, but in this case they probably really are). What they cite as strengths are equally absurd for reasons noted above.

They note how the different coding dimensions got similar results, not recognizing that this is because they were measuring the same phenomena. They complain, “No tobacco industry–related papers expressed concerns about the health effects of e-cigarettes.”, not recognizing that this means that (a) they did not find anything alarming because (as far as we can tell) there is nothing alarming to find if you use valid methods, and (b) unlike the “no COI” researchers, they are proper scientists who do not draw conclusions about outcomes (let alone policies) that were not assessed in their research. They suggest that their results are similar to those from other fields, apparently oblivious to the huge differences among those situations and literatures. And of course they liken their result to the completely dissimilar ancient history when cigarette companies did produce dishonest research. They ramble on about this for a while.

Their second biggest self-own is, “Very concerning is that the tobacco industry papers are cited more often than papers written by independent [sic] researchers.” Hmm, I wonder if there is a reason for that? It also turns out that the New York Review of Books is cited more often than the National Enquirer.

Their greatest self-own, however, is, “Penalties to authors who do not disclose [COI] correctly have been proposed….” Um, I have some bad news for you.

FTFY.

Finally, this is what the abstract of the paper should have said, based on the above analysis:

In the vaping research space, the major corporations can afford the highest-quality personnel and equipment, and pay researchers to focus and take the time to do the work carefully and correctly. They are under enormous pressure to make sure their methods and results are valid and replicable, and to carefully avoid engaging in political editorializing when reporting their study results. By contrast, university and government research generally relies on students or other low-cost researchers. Those authors are usually under serious time pressure and often working on multiple projects, but face basically no pressure to do legitimate work. They feel free to spin the results and editorialize about their personal political opinions, and there are no repercussions when their methods or results are demonstrated to be fatally flawed. In addition, most such researchers are dependent upon (or hope to become dependent upon) grants from anti-vaping agencies, which are likely to not be forthcoming if the papers do not support the political agenda.

We assessed whether authors of papers about vape chemistry engaged in political spin in their abstracts and cross-tabulated that against funding sources. Our research found that papers that did not have the benefits of industry funding were much more likely to make unsupported anti-vaping political statements. Presumably this was mostly driven by them lacking the pressure to report accurately and avoid political spin, though many might have also used flawed or biased methodology (which we did not attempt to assess).

It is impossible to separate political statements that were motivated by financial conflicts of interest from those motivated by personal political conflicts of interest. However, we did observe that among the abstracts that did not have the benefits of industry funding, there was little difference in political spin between those whose authors were known to be under financial pressure to produce anti-vaping results (because they receive funding from U.S. anti-vaping agencies or WHO) and the others. This suggests that the politicizing in those papers is driven primarily by non-financial conflicts of interest, as well as the general sloppiness of university research papers, and that anti-vaping funders are largely just rewarding such bias rather than causing it.

What conflict of interest accusations really mean (with a tie to The Times’s attack on GTNF participants)

by Carl V Phillips

Public health activists are extremely fond of using ad hominem attacks to avoid admitting they have no substantive defense against their critics. They are not alone, of course, with many supporters of other indefensible causes doing the same — e.g., anti-agritech activists, “alternative” energy advocates, alt-right adolescents on Twitter, etc. These attacks most often take the form of claiming “conflict of interest”. Endless ink has been spilled on the fact that resorting to an ad hominem attack is practically an admission that one’s opponent is right. But there is far too little discussion about the actual substantive content of the COI. Basically, what is dressed up as genteel productive discussion is actually a bald accusation that someone is lying, and moreover usually that they are only choosing to lie because of some (often trivial) transfer of funds. Continue reading

An old letter to the editor about Glantz’s ad hominems

by Carl V Phillips

I am going through some of my old files of unpublished (or, more often, only obscurely published) material, and though I would post some of it. While I suspect you will find this a poor substitute for my usual posts, I hope there is some interest (and implicit lessons for those who think any of this is new), and posting a few of these will keep this blog going for a few weeks.

This one, from 2009, was written as a letter to the editor (rejected by the journal — surprise!) by my team at the University of Alberta School of Public Health. It was about this rant, “Tobacco Industry Efforts to Undermine Policy-Relevant Research” by Stanton Glantz and one of his deluded minions, Anne Landman, published in the American Journal of Public Health (non-paywalled version if for some unfathomable reason you actually want to read it). The authorship of our letter was Catherine M Nissen, Karyn K Heavner, me, and Lisa Cockburn. 

The letter read:

——–

Landman and Glantz’s paper in the January 2009 issue of AJPH is a litany of ad hominem attacks on those who have been critical of Glantz’s work, with no actual defense of that work. This paper seems to be based on the assumption that a researcher’s criticism should be dismissed if it is possible to identify funding that might have motivated the criticism. However, for this to be true it must be that: (1) there is such funding, (2) there is reason to believe the funding motivated the criticism, and (3) the criticism does not stand on its own merit. The authors devote a full 10 pages to (1), but largely ignore the key logical connection, (2). This is critical because if we step back and look at the motives of funders (rather than just using funding as an excuse for ignoring our opponents), we see that researchers tend to get funding from parties that are interested in their research, even if the researcher did not seek funding from that party (Marlow, 2008).

Most important, the authors completely ignore (3). Biased motives (whether related to funding or not) can certainly make us nervous that authors have cited references selectively, or in an epidemiology study have chopped away years of data to exaggerate an estimated association, or have otherwise hidden something. [Note: In case it is not obvious, these are subtle references to Glantz’s own methods.] But a transparent valid critique is obviously not impeached by claims of bias. The article’s only defense against the allegation that Glantz’s reporting “was uncritical, unsupportable and unbalanced” is to point to supposed “conflicts of interest” of the critics. If Glantz had an argument for why his estimates are superior to the many competing estimates or why the critiques were wrong, this would seem a convenient forum for this defense, but no such argument appears. Rather, throughout this paper it seems the reader is expected to assume that Glantz’s research is infallible, and that any critiques are unfounded. This is never the case with any research conducted, and surely the authors must be aware that any published work is open to criticism.

Indeed, presumably there are those who disagree with Glantz’s estimates who conform to his personal opinions about who a researcher should be taking funding from, and yet we see no response to them. For example, even official statistics that accept the orthodoxy about second hand smoke include a wide range of estimates (e.g., the California Environmental Protection Agency (2005) estimated it causes 22,700-69,600 cardiac deaths per year), and much of the range implies Glantz’s estimates are wrong. But in a classic example of “a-cell epidemiology” [Note: This is a metaphoric reference to the 2×2 table of exposure status vs. disease status; the cell counting individuals with the exposure and the disease is usually labeled “a”.], Glantz has collected exposed cases to report, but tells us nothing of his critics who are not conveniently vulnerable to ad hominem attacks.

It is quite remarkable that given world history, and not least the recent years in the U.S., people seem willing to accept government as unbiased and its claims as infallible. Governments are often guilty of manipulating research (Kempner, 2008). A search of the Computer Retrieval of Information on Scientific Projects database (http://report.nih.gov/crisp/CRISPQuery.aspx) on the National Institute of Health’s website found that one of the aims of the NCI grant that funded Landman and Glantz’s research (specified in their acknowledgement statement) is to “Continue to describe and assess the tobacco industry’s evolving strategies to influence the conduct, interpretation, and dissemination of science and how the industry has used these strategies to oppose tobacco control policies.” Cleary this grant governs not only the topic but also the conclusions of the research, a priori concluding that the tobacco industry continues to manipulate research, and motivating the researcher to write papers that support this. Surely it is difficult to imagine a clearer conflict of interest than, “I took funding that required me to try to reach a particular conclusion.”

The comment “[t]hese efforts can influence the policymaking process by silencing voices critical of tobacco industry interests and discouraging other scientists from doing research that may expose them to industry attacks” is clearly ironic. It seems to describe exactly what the authors are attempting to do to Glantz’s critics, discredit and silence them, to say nothing of Glantz’s concerted campaign to destroy the career of one researcher whose major study produced a result Glantz did not like (Enstrom, 2007; Phillips, 2008). If Glantz were really interested in improving science and public health, rather than defending what he considers to be his personal turf, he would spend his time explaining why his numbers are better. Instead, he spends his time outlining (and then not even responding to) the history of critiques of his work, offering only his personal opinions about the affiliations of his critics in his defense.

References

1. Landman, A., and Glantz, Stanton A. Tobacco Industry Efforts to Undermine Policy-Relevant Research. American Journal of Public Health. January 2009; 99(1):1-14.

2. Marlow, ML. Honestly, Who Else Would Fund Such Research? Reflections of a Non-Smoking Scholar. Econ Journal Watch. 2008 May; 5(2):240-268.

3. California Environmental Protection Agency. Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Executive Summary. June 2005.

4. Kempner, J. The Chilling Effect: How Do Researchers React to Controversy? PLoS Medicine 2008; 5(11):e222.

5. Enstrom, JE. Defending legitimate epidemiologic research: combating Lysenko pseudoscience. Epidemiologic Perspectives & Innovations 2007, 4:11.

6. Phillips, CV. Commentary: Lack of scientific influences on epidemiology. International Journal of Epidemiology. 2008 Feb;37(1):59-64; discussion 65-8.

7. Libin, K. Whither the campus radical? Academic Freedom. National Post. October 1, 2007.

——–

Our conflict of interest statement submitted with this was — as has long been my practice — an actual recounting of our COIs, unlike anything Glantz or anyone in tobacco control would ever write. It read:

The authors have experienced a history of attacks by those, like Glantz, who wish to silence heterodox voices in the area of tobacco research; our attackers have included people inside the academy (particularly the administration of the University of Alberta School of Public Health (National Post, 2007)), though not Glantz or his immediate colleagues as far as we know. The authors are advocates of enlightened policies toward tobacco and nicotine use, and of improving the conduct of epidemiology, which place us in political opposition to Glantz and his colleagues. The authors conduct research on tobacco harm reduction and receive support in the form of a grant to the University of Alberta from U.S. Smokeless Tobacco Company; our research would not be possible if Glantz et al. succeeded in their efforts to intimidate researchers and universities into enforcing their monopoly on funding. Unlike the grant that supported Glantz’s research, our grant places no restrictions on the use of the funds, and certainly does not pre-ordain our conclusions. The grantor is unaware of this letter, and thus had no input or influence on it. Dr. Phillips has consulted for U.S. Smokeless Tobacco Company in the context of product liability litigation and is a member of British American Tobacco’s External Scientific Panel.

Newsflash: Tobacco companies are incredibly timid

by Carl V Phillips

In the previous post, I commented upon the most recent in the endless series of analysis-free and truth-free McCarthyist demands from “public health” to censor industry-funded research (as well as upon what I felt was an inadequate retort to it). I quipped on Twitter that every time I read one of those pieces, I feel like I am reading @DPRK_News. If you are not familiar, that is a great parody feed that satirizes what official communications from North Korea might say about domestic and foreign events. The parody is grounded in filtering events through over-the-top premises about the depravity of the West and the success of the North Korean government. It is not exactly a mystery why the political statements of core “public health” people resemble what we might expect to hear from a cult of personality that keeps its subjects completely cut off from reality, bragging about its performance (which is, of course, mind-boggling disastrous), while making up crazy stories about the rest of the world. Continue reading

A give-and-take on censoring ecig research that gets almost everything wrong

by Carl V Phillips

I have watched with some amusement the swirl of attention around this op-ed (for that is what it is) by Jim McCambridge, in the journal Addiction, calling for further censorship of THR research, and this response to it in a blog post by Neil McKeganey and Christopher Russell. My amusement is first because it seems like this exchange feels like it was written 15 years ago and second because of the huge oversights by all involved. Continue reading

SRNT believes research should be replicated (when they don’t like the results)

by Carl V Phillips

My attention was called to this gem of an editorial, “Conflicts of Interest and Solicited Replication Attempts” by the Nicotine and Tobacco Research (NTR) Editor-in-Chief, Marcus Munafò. NTR is the journal of the Society for Research on Nicotine and Tobacco (SRNT) and the slightly more honest and scientifically sound of the anti-tobacco journals. This editorial offers a new and different reflection on just how out of touch with real science tobacco controllers are. Continue reading

Sunday Science Lesson: So much of what is wrong with public health, in one short rejection letter

by Carl V Phillips

I finally got around to submitting our study about the failure of peer review in public health. (If someone wants to write a guest science lesson post about how to be more efficient about just getting things done instead of letting them languish, it would be most welcome.) We had decided to submit it first to BMC Public Health (BMCPH), the journal whose reviews and publications we studied. You might recall that we discovered that the journal reviews we analyzed were mostly content-free, or close to it, despite the many serious problems we (Igor Burstyn, Brian Carter, and I, with contributions from Clive Bates) identified in the submissions. The journal peer-review process did not manage to fix any of the major problems — not the fatal flaws that should have sent the paper back to the drawing board, nor even the simpler errors that could have been fixed with a rewrite. We decided we owed it to BMCPH to give them the chance to step up and publish the paper, and perhaps then do some soul-searching about it. Continue reading

Complaints about conflict of interest are designed to maximize conflict of interest

by Carl V Phillips

A colleague who found himself the target of the “you have a conflict of interest!” bullshit game was invited to write his analysis of the nature of conflict of interest as it relates to e-cigarette research. He asked me for input and several points occurred to me. I am writing them up here, in an admittedly disorganized fashion, for possible use in that project. Continue reading